| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |